Reggie Bowerman is a Midwestern kind of guy.
So when his employer of nearly a decade, MGI Pharma, packed up and moved to New Jersey last year, Bowerman was one of several local employees who chose not to make the move.
Instead, he became CEO of DiaMedica, a pharmaceutical company based in Winnipeg, Manitoba.
“I made an assumption that [Canadians] might look at the world with more of the same perspective than a guy from Manhattan might. Since then, it’s been nothing but reinforced,” said Bowerman, who is based in the Twin Cities and commutes to Winnipeg as necessary.
Bowerman’s story is an example of the growing number of cross-border ties between Minnesota-based biotech communities and their Canadian counterparts. The trend comes on the heels of several years of networking efforts by Minnesota bioscience boosters, who believe the state could be on the cusp of a sea change of collaboration with our neighbors to the north. (Continue reading…)